false
Catalog
SMI, Psychotropics, and Sexuality
Presentation Slides
Presentation Slides
Back to course
Pdf Summary
This document is a transcript of a webinar titled "SMI, Psychotropics and Sexuality" as part of the Clinical Support System for Serious Mental Illness (CSS-SMI), an initiative funded by the Substance Abuse and Mental Health Services Administration (SAMHSA) and implemented by the American Psychiatric Association (APA). The webinar focuses on the impact of commonly used psychiatric medications on sexuality and potential solutions to minimize sexual issues. It also discusses prescribing considerations related to psychiatric medications and adverse sexual issues.<br /><br />The webinar begins with a historical perspective on sexuality, including the ancient Greek and Roman view of manhood, Freud's psychoanalysis, and the shifting definitions of frigidity and female sexuality. It then explores the relationship between mental illness and sexuality, highlighting studies that show the impact of mental illness on sexual function and the need for support and treatment for both patients and their partners.<br /><br />The document also provides information on the assessment of sexuality, assessment tools that can be used, and the importance of communication and informed consent when discussing sexual side effects of medications with patients. It outlines the medications commonly associated with sexual dysfunction, including antipsychotics, antidepressants, benzodiazepines, beta-blockers, and diuretics.<br /><br />The document further delves into the mechanism of action of antipsychotics, mood stabilizers, and anxiolytics on sexual function, as well as the management of antipsychotic-related sexual dysfunction. It also mentions the impact of bipolar disorder on sexual function and the effects of specific bipolar medications on sexuality.<br /><br />The document concludes with non-pharmacological treatment strategies for psychotropic-induced sexual dysfunction, such as enhancing stimulation, managing pain, and encouraging non-coital behaviors. It also highlights psychotherapeutic options and provides a list of references for further reading.<br /><br />Overall, the webinar aims to provide healthcare professionals with information and strategies to address the impact of psychotropic medications on sexuality in individuals with serious mental illness.
Keywords
SMI
Psychotropics
Sexuality
Clinical Support System
Assessment of sexuality
Antipsychotics
Antidepressants
Benzodiazepines
Bipolar disorder
Non-pharmacological treatment strategies
Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.
×
Please select your language
1
English